Identification of a four-gene panel predicting overall survival for lung adenocarcinoma

BACKGROUND: Lung cancer is the most frequently diagnosed carcinoma and the leading cause of cancer-related mortality. Although molecular targeted therapy and immunotherapy have made great progress, the overall survival (OS) is still poor due to a lack of accurate and available prognostic biomarkers....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunyu, Long, Qizhong, Zhang, Danni, Li, Jun, Zhang, Xianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720456/
https://www.ncbi.nlm.nih.gov/pubmed/33287749
http://dx.doi.org/10.1186/s12885-020-07657-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720456/
https://www.ncbi.nlm.nih.gov/pubmed/33287749
http://dx.doi.org/10.1186/s12885-020-07657-9

Ejemplares similares